|
Study of Individualized Instruction versus Pamphlet in Systemic Lupus Erythematosus Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about Study of Individualized Instruction versus Pamphlet in Systemic Lupus Erythematosus conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Study of Individualized Instruction versus Pamphlet in Systemic Lupus Erythematosus Clinical research trials and Study of Individualized Instruction versus Pamphlet in Systemic Lupus Erythematosus health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including Study of Individualized Instruction versus Pamphlet in Systemic Lupus Erythematosus. Study of Individualized Instruction versus Pamphlet in Systemic Lupus Erythematosus Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Study of Individualized Instruction versus Pamphlet in Systemic Lupus Erythematosus clinical trial. Test subjects typically receive the most expert healthcare available for their Study of Individualized Instruction versus Pamphlet in Systemic Lupus Erythematosus condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of Individualized Instruction versus Pamphlet in Systemic Lupus Erythematosus Study of Individualized Instruction versus Pamphlet in Systemic Lupus Erythematosus
Study of Individualized Instruction versus Pamphlet in Systemic Lupus Erythematosus
For Condition: Systemic Lupus Erythematosus
Status: Completed
Sponsor(s): National Center for Research Resources (NCRR) , Virginia Commonwealth University
Synopsis: OBJECTIVES: I. Evaluate an educational program that has been pretested for cultural appropriateness and literacy requirements in patients with systemic lupus erythematosus (SLE). II. Assess the impact of this educational program on patients with SLE, with an emphasis on recognizing cardinal symptoms, coping with fatigue, regulating medications, and communicating with the physician.
Details: PROTOCOL OUTLINE: Patients are randomly assigned to 1 of 2 groups. One group participates in an educational program administered and coordinated by a health educator. The program includes 1 or 2 educational sessions emphasizing practical advice, each lasting approximately 1.5 hours; social support from a patient-identified management partner; and behavioral reinforcement from health center staff, the patient partner, and written and audio materials. The control group receives patient educational materials consistent with usual care (pamphlets). Patients are followed at 6, 12, 24, and 36 months.
Eligibility:
Study Type: Interventional, Educational/Counseling/Training, Randomized, Efficacy Study
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: Confirmed systemic lupus erythematosus (SLE) using American College of Rheumatology criteria Recruitment from the Medical College of Virginia SLE registry
Total Enrollment: 150
Location and Contact Information:
Overall Study Official:
W.Roberts, Study Chair, Virginia Commonwealth University
Additional Information:
Study ID Numbers: 199/11686; VCU-92123A
Study Start Date: December 1994
Record last reviewed: December 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004756
Other Systemic Lupus Erythematosus Studies:
1. Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women with Active Systemic Lupus Erythematosus
2. Study of Families with Twins or Siblings Discordant for Rheumatic Disorders
3. Safety of Estrogens in Lupus: Birth Control Pills
4. Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders
5. Monoclonal Antibody Treatment for Systemic Lupus Erythematosus
Related Studies:
Other Systemic Lupus Erythematosus Clinical Trials
Other Clinical Trials
Other Clinical Trials
Study of Individualized Instruction versus Pamphlet in Systemic Lupus Erythematosus
|
|
|
|
|
|
|
|